. Author manuscript; available in PMC: 2015 Jun 13.

Published in final edited form as: J Consult Clin Psychol. 2012 Dec 17;81(2):284–298. doi: 10.1037/a0030814

Table 5.

Means and Standard Deviations (in Parentheses) for Main Study Outcomes for Women With Elevated PTSD Scores at Baseline (≥20) Across Baseline and 1-, 6-, and 12-Month Follow-Ups

Outcome	Baseline	1 month	6 month	12 month
PTSDTOT
Treatment	44.91 (23.13)	26.75 (21.20)	22.60 (23.49)	24.28 (19.89)
Control	45.25 (19.07)	41.30 (22.94)	36.86 (24.94)	34.79 (30.60)
HAM–D
Treatment	14.86 (7.51)	7.85 (4.36)	6.52 (5.60)	9.72 (6.07)
Control	13.42 (5.56)	12.35 (7.27)	11.71 (5.97)	10.42 (6.07)
HIV symptoms
Treatment	0.33 (0.48)	0.29 (0.46)	0.15 (0.37)	0.28 (0.46)
Control	0.33 (0.48)	0.35 (0.49)	0.57 (0.51)	0.42 (0.51)
Sample size^a
Treatment	24^b	20^c	21^d	18
Control	24	23	21	20^e

Note. PTSDTOT = Davidson PTSD (Posttraumatic Stress Disorder) Scale; HAM–D = Hamilton Depression Scale; HIV symptoms = HIV symptom checklist.

Sample size given is for PTSDTOT. Where the sample size differs for other variables, the sample size is as follows:

HAM–D (N = 21);

HIV symptoms (N = 21);

HIV symptoms (N = 20);

HAM–D and HIV symptoms (N = 19).